RxDoctor Payments Data

Valentino Ciullo

Foot & Ankle Surgery · Philadelphia, PANPI 1215974720

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $5,271 of the $6,191 with a category attached, or 85.1%. Smith+Nephew accounts for 62.1% of it on its own, with 18 other manufacturers making up the rest. Reporting peaked in 2021 at $2,916 and has fallen 99.4% since, to $16 in 2023.

$6,191in general payments, 2019–2025

Across 165 payments — averaging $37.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$4K
  • Integra Lifesciences Corporation$785
  • Organogenesis Inc.$498
  • KCI USA, Inc.$415
  • Osiris Therapeutics Inc.$155
  • Biotissue Holdings Inc.$91
  • plus $400 from 13 others

What the payments were for

  • Travel & lodging$92015%
  • Food & beverage$5,27185%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,191 in reported general payments places this provider in the 70th percentile of 575 foot & ankle surgery providers in Pennsylvania.

See all foot & ankle surgery providers in Pennsylvania →

Other foot & ankle surgery in Philadelphia

See the full list for Pennsylvania →

Where these figures come from

Is this you, or does something look wrong? →